CD4 and lung carcinoma: Koh et al. used anti-Gr1 or anti-Ly6G to deplete MDSCs in mice with lung cancer; the activity and number of CD4+ and CD8+ T cells, memory T cells, and other immune cells were increased, and the secreted antitumor factors were also increased, which could promote the antitumor immune response [5, 6].